Skip to content
AnalystLens
Back to EWBalance Sheet

Edwards Lifesciences Long-Term Debt 2009-2026 | EW

Annual FY2009–FY2025 · quarterly through Q2 FY2026

Latest annual · FY2025

$598.3M

+0.1%YoY vs FY2024Source: 10-KFY2025

From $90.3M in FY2009 to $598.3M in FY2025: 6.6× in 16 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$599M+0.1%$599M+0.1%Not reportedNot reported
FY25$598M+0.1%$598M+0.1%$598M+0.1%$598M+0.1%
FY24$597M+0.1%$597M+0.1%$598M+0.1%$598M+0.1%
FY23$597M+0.1%$597M+0.1%$597M+0.1%$597M+0.1%
FY22$596M+0.1%$596M+0.1%$596M+0.1%$596M+0.1%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+0.1%

FY2020
$595.0M
FY2025
$598.3M

5 years selected · on the chart

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

  1. $598.3M
YoY changeLargest recent move−46.7%in FY17Latest +0.1%

2 older moves run past ±50% (largest +213.3%); point at, tap or drag across the bars to read one.

Long-Term Debt, period by period

PeriodValueChangeSource
FY2025$598.3M+0.1%10-K
FY2024$597.7M+0.1%10-K
FY2023$597.0M+0.1%10-K
FY2022$596.3M+0.1%10-K
FY2021$595.7M+0.1%10-K
FY2020$595.0M+0.1%10-K
FY2019$594.4M+0.1%10-K
FY2018$593.8M+35.4%10-K
FY2017$438.4M−46.7%10-K
FY2016$822.3M+37.8%10-K
FY2015$596.9M−0.2%10-K
FY2014$598.1M+0.8%10-K
FY2013$593.1M+213.3%10-K
FY2012$189.3M+25.9%10-K
FY2011$150.4M+66.6%10-K
FY2009$90.3M—10-K

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is Edwards Lifesciences's current long-term debt?

Edwards Lifesciences (EW) annual long-term debt for 2025 was $598.3M, a 0.10% increase from 2024. Edwards Lifesciences long-term debt for the quarter ending June 30, 2026 was $598.7M.

What was Edwards Lifesciences's long-term debt in 2024?

Edwards Lifesciences annual long-term debt for 2024 was $597.7M, a 0.12% increase from 2023.

What was Edwards Lifesciences's long-term debt in 2023?

Edwards Lifesciences annual long-term debt for 2023 was $597.0M, a 0.12% increase from 2022.

What is Edwards Lifesciences's 5-year long-term debt CAGR?

Edwards Lifesciences long-term debt grew at a compound annual growth rate (CAGR) of 0.11% from FY2020 to FY2025, going from $595.0M to $598.3M over 5 years.

Company
Edwards Lifesciences
Ticker
EW
Sector
Other
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies